Skip to main content

The Simply Good Foods Company Reports Fiscal Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Outlook

DENVER, April 09, 2026 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a leader in the Nutritional Snacking Category, today reported financial results for the thirteen and twenty-six weeks ended February 28, 2026. Second Quarter Summary:(1)Net sales of $326.0 million versus $359.7 million Net loss of $159.7 million versus net income of $36.7 million Loss per diluted share of $1.73 versus earnings per diluted share of $0.36 Adjusted Diluted EPS(2) of $0.45 versus $0.46 Adjusted EBITDA(3) of $55.5 million versus $68.0 millionUpdating Fiscal Year 2026(4) Outlook:Net sales expected to range between $1.31 and $1.35 billion, or -10% to -7% year-over-year Gross margins expected to decline between 300 and 350 basis points year-over-year Adjusted EBITDA expected to range between...

Continue reading

ConnectOne Bancorp, Inc. to Host 2026 First Quarter Results Conference Call on April 23, 2026

ENGLEWOOD CLIFFS, N.J., April 09, 2026 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced that it plans to release results for the first quarter ended March 31, 2026, before the market opens on Thursday, April 23, 2026. Management will also host a conference call and audio webcast at 10:00 a.m. ET on April 23, 2026, to review the Company’s financial performance and operating results. Chairman and Chief Executive Officer Frank Sorrentino III and Senior Executive Vice President and Chief Financial Officer William S. Burns will host the call. The conference call dial-in number is 1 (646) 307-1963, access code 8368502. Please dial in at least five minutes before the start of the call to register. An audio webcast of the conference...

Continue reading

GXO Appoints Commercial Leader to Accelerate Scalable Growth and Strengthen Long-Term Partnerships

Ajit Kara joins GXO as Senior Vice President of Account ManagementKara will lead the Account Management organization with responsibility for enabling scalable growth, value creation and strengthening long-term partnerships.Industry veteran Ajit Kara joins GXO as Senior Vice President of Account Management GREENWICH, Conn., April 09, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure‑play contract logistics provider, announced today that Ajit Kara has joined GXO as Senior Vice President, Account Management, reporting to Chief Commercial Officer Karen Bomber. In this newly created role, Kara will lead the Account Management organization with responsibility for enabling scalable growth, value creation and strengthening long-term partnerships. He will be based at GXO’s headquarters in Greenwich,...

Continue reading

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

New preclinical data for FHD-909 (LY4050784) reinforcing the potential for expansion opportunities in combination with an anti-PD-1 antibody in SMARCA4 (BRG1)-mutant lung cancer Preclinical characterization of FHT-171, a selective CBP degrader with promise in ER+ breast cancer Progress across Selective EP300 degrader in hematological malignancies and Selective ARID1B degrader in ARID1A-mutant tumors WATERTOWN, Mass., April 09, 2026 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that it will have multiple oral and poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting being held April 17-22, 2026, in San Diego, California....

Continue reading

Shoals Technologies Group, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call

PORTLAND, Tenn., April 09, 2026 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2026 results before market open on Tuesday, May 5, 2026, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day. Interested investors and other parties can access the live webcast through the Investor Relations section of the Company’s website at https://investors.shoals.com. An archived replay of the webcast will be available shortly after the event concludes. About Shoals Technologies Group, Inc.Shoals Technologies Group is a leading manufacturer of advanced electrical infrastructure solutions for mission‑critical applications across utility‑scale solar, battery storage, and data center power systems. Since its founding in...

Continue reading

ScottsMiracle-Gro Completes Divestiture of Hawthorne Subsidiary

Sale to Vireo Growth enhances focus on North American consumer lawn and garden business MARYSVILLE, Ohio, April 09, 2026 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that it has completed the sale of its subsidiary The Hawthorne Gardening Company to Vireo Growth, Inc. Hawthorne was acquired by Vireo Growth (CSE: VREO; OTCQX: VREOF) in exchange for Vireo shares that are being held by an independent strategic partner and will be reported in the Company’s financial statements among its other investments. The Company also reaffirmed its fiscal 2026 guidance, as the divestiture does not impact the full-year outlook. “The divestiture of Hawthorne demonstrates further progress toward our strategy to drive long-term growth...

Continue reading

OTC Markets Group Welcomes Cardiff Lexington Corporation to OTCQX

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cardiff Lexington Corporation (OTCQX: CDIX), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms , has qualified to trade on the OTCQX® Best Market. Cardiff Lexington Corporation upgraded to OTCQX from the OTCQB® Venture Market. Cardiff Lexington Corporation begins trading today on OTCQX under the symbol “CDIX.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market provides investors with a premium U.S. public market to research and trade the shares of investor-focused companies. Graduating to the OTCQX Market...

Continue reading

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Dr. Sara Kenkare-Mitra as a Strategic Advisor. Dr. Kenkare-Mitra brings nearly three decades of experience in biologics and small molecule drug discovery and development, with a proven track record of global regulatory approvals and commercial launches across oncology, immunology, neurodegeneration, ophthalmology, and respiratory diseases. “Sara is a highly accomplished leader and respected drug developer, and we are thrilled to welcome her as a Strategic Advisor,” said Talat Imran, Chief Executive Officer of Rani. “Her experience across discovery, development, and commercialization...

Continue reading

C4 Therapeutics Expands Long-Term Partnership with Roche Through New Collaboration Agreement Focused on Discovering and Developing Degrader-Antibody Conjugates (DACs)

Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third Target C4T to Develop Degraders With Payload Properties; Roche to Conjugate Payloads to Targeted Antibodies C4T to Receive $20 Million Upfront Payment and Eligible to Receive Over $1 Billion in Discovery, Development and Commercial Milestones, in Addition to Future Royalties WATERTOWN, Mass., April 09, 2026 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science today announced that it has entered into a new collaboration agreement with Roche (SIX: RO, ROP; OTCQX: RHHBY) to advance research in the emerging degrader-antibody conjugate (DAC) modality. Working together, C4T and Roche will combine antibody-drug conjugation...

Continue reading

Cornerstone Community Financial Credit Union Launches GenGrow Family Wallet Youth Banking Platform with Rego Payment Architectures, Inc.

Michigan- and Ohio-based credit union expands digital banking experience with a secure, parent-controlled financial solution for families BLUE BELL, Pa., April 09, 2026 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), the leading white-label family financial lifecycle platform for financial institutions, today announced that Cornerstone Community Financial Credit Union has launched its youth banking platform, GenGrow Family Wallet, powered by REGO. The new offering enables families to introduce children to financial concepts through a secure, parent-controlled experience, fully integrated within Cornerstone’s existing digital banking platform. “Our mission has always been centered on supporting our members and their families at every stage of life,” said Steve Flores, Chief Innovation Officer at Cornerstone...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.